Enhanced Engagement for Frailty

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Chicago, Chicago, IL
Frailty+2 More
Enhanced Engagement - Behavioral
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function.

Eligible Conditions

  • Frailty
  • Frailty Syndrome

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 15 Secondary · Reporting Duration: 6 months

6 months
1-leg balance
2-minute step in place
30 second arm curl
4 meter usual walk
6-minute walk test
Back stretch
Balance Poses
Chair sit and reach
Grip Strength
Loneliness
Physical activity
Physical activity and Sedentary behavior
QoL
Static Balance Poses
Timed Chair Stands
Timed up and go

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Physical Exercise Handouts
1 of 2
EngAGE
1 of 2
Active Control
Experimental Treatment

248 Total Participants · 2 Treatment Groups

Primary Treatment: Enhanced Engagement · No Placebo Group · N/A

EngAGE
Behavioral
Experimental Group · 1 Intervention: Enhanced Engagement · Intervention Types: Behavioral
Physical Exercise Handouts
Behavioral
ActiveComparator Group · 1 Intervention: Standard Engagement · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Closest Location: University of Chicago · Chicago, IL
Photo of University of Chicago 1Photo of University of Chicago 2Photo of University of Chicago 3
2004First Recorded Clinical Trial
2 TrialsResearching Frailty
705 CompletedClinical Trials

Who is running the clinical trial?

University of ChicagoLead Sponsor
909 Previous Clinical Trials
726,649 Total Patients Enrolled
2 Trials studying Frailty
165 Patients Enrolled for Frailty
Rush UniversityOTHER
33 Previous Clinical Trials
21,233 Total Patients Enrolled
National Opinion Research CenterOTHER
10 Previous Clinical Trials
135,635 Total Patients Enrolled
Megan Huisingh-Scheetz, MDPrincipal InvestigatorUniversity of Chicago

Eligibility Criteria

Age 65+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You require any assistance to leave the home.\n
You have a SPPB score of less than or equal to 8 but greater than 3 on a 12-point scale to target moderate but not severe functional impairment.
If you are 65 years or older, you are not eligible for this study.
You can read 14 point font from a 2-foot distance on a tablet-sized screen.
You can hear spoken voice from 2 feet away.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References